Advertising

NYSE:ARE

189.56
4.02 (2.17%) 1d
0
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »
BUY
Admires the management, but he doesn't like commercial office space now, but ARE's tenants are American biotech and life science companies, which carry the costs of. A lot of value here.
REAL ESTATE
TOP PICK
The only REIT in health sciences, and is benefiting from demand to treat and cure COVID-19 and other diseases. Though considered an office REIT, she notes that many of its tenants cannot work from home. Rent collection is impressive at 99%, because life sciences are deemed essential. It leased 1 million sq. feet in Q2, consistent with prior quarters with rents 15% higher. Likes its assets, and it's a niche way to play this sector. (Analysts’ price target is $181.56)
REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 05/18, Up 33%) When he called it, ARE wasn't cheap. They hold life sciences properties, which is solid and lucrative (fuelled by R&D spending). They can raise rents by 20-30% annually with these companies, which means strong cash flow growth.
REAL ESTATE
PAST TOP PICK
(A Top Pick Aug 16/18, Up 24%) One of the best capital compounders out there. They build life sciences buildings on campuses across the US. Biotech companies co-locate on these campuses, creating great opportunities. The fundamentals remain positive and he continues to hold it.
REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.
REAL ESTATE
TOP PICK
The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)
REAL ESTATE
PAST TOP PICK
(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.
REAL ESTATE
TOP PICK

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

REAL ESTATE
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Alexandria Real Estate Equities(ARE-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Alexandria Real Estate Equities is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Alexandria Real Estate Equities(ARE-N) Frequently Asked Questions

What is Alexandria Real Estate Equities stock symbol?

Alexandria Real Estate Equities is a American stock, trading under the symbol ARE-N on the New York Stock Exchange (ARE). It is usually referred to as NYSE:ARE or ARE-N

Is Alexandria Real Estate Equities a buy or a sell?

In the last year, there was no coverage of Alexandria Real Estate Equities published on Stockchase.

Is Alexandria Real Estate Equities a good investment or a top pick?

Alexandria Real Estate Equities was recommended as a Top Pick by on . Read the latest stock experts ratings for Alexandria Real Estate Equities.

Why is Alexandria Real Estate Equities stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Alexandria Real Estate Equities worth watching?

0 stock analysts on Stockchase covered Alexandria Real Estate Equities In the last year. It is a trending stock that is worth watching.

What is Alexandria Real Estate Equities stock price?

On 2022-01-28, Alexandria Real Estate Equities (ARE-N) stock closed at a price of $189.56.